FARADARMANI on HIV/AIDS

Study of short time effect of FARADARMANI on CD4 level

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201108014076N4

Enrollment

Registered

2012-01-01

Start date

2011-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV / AIDS. Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

Interventions

The patients will be asked starting "Faradarmani" during fifteen minutes with their closed eyes under guide and supervision of "Faradarmangar". Also "Faradarmangar" will ask them for three times a day

Rehabilitation

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1- age over 18 and below 45 2- Accepting the consent form 3- Not going under adjuvant therapy 4- No Active drug addiction 5- CD4 count > 200 cell/ml2

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
CD4 count. Timepoint: Monthly. Method of measurement: Blood Sampling, Cell/ m2 of blood.	—

Secondary

Measure	Time frame
Questioner MSCL , SCL90. Timepoint: Monthly. Method of measurement: Questioner.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Ahmad Seyed Alinaghi

Iranian Research center for HIV/AIDS

ircha@tums.ac.ir+98 21 6694 7984

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026